One of the most promising drugs for Alzheimer's disease fails in clinical trials

To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer’s disease and come up short, we can now add three more. An experimental drug called idalopirdine failed to help people with mild to moderate Alzheimer’s disease in a trio of trials that involved 2,525...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Thu 11 Jan 18 from Medical Xpress

One of the most promising drugs for Alzheimer's disease fails in clinical trials, Tue 9 Jan 18 from L.A. Times

Despite Its Modest Goals, Promising Alzheimer’s Drug Is Latest In Long String Of Failures To Combat Disease

The failure may mark the unraveling of an approach to Alzheimer's treatment that has held hope: increasing the supply of the brain chemical serotonin in patients. Scientists and investors, however, ...

Wed 10 Jan 18 from Kaiser Health News

  • Pages: 1

Bookmark

Bookmark and Share